News
-
-
PRESS RELEASE
DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa
DEBRA Research announces impact investment into Nova Anchora to advance protein therapy for Epidermolysis Bullosa. Global investors support development of NvA-011 for rare skin disorder treatment -
-